BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Suh Y, Yoon CH, Kim RK, Lim EJ, Oh YS, Hwang SG, An S, Yoon G, Gye MC, Yi JM. Claudin-1 induces epithelial-mesenchymal transition through activation of the c-Abl-ERK signaling pathway in human liver cells. Oncogene. 2012;Nov 19; Epub ahead of print. [PMID: 23160379 DOI: 10.1038/onc.2012.505] [Cited by in Crossref: 117] [Cited by in F6Publishing: 112] [Article Influence: 11.7] [Reference Citation Analysis]
Number Citing Articles
1 Zhu F, Duan Y, Bao W, Liu W, Yang Y, Cai H. HtrA1 regulates epithelial–mesenchymal transition in hepatocellular carcinoma. Biochemical and Biophysical Research Communications 2015;467:589-94. [DOI: 10.1016/j.bbrc.2015.09.105] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
2 Greuber EK, Smith-Pearson P, Wang J, Pendergast AM. Role of ABL family kinases in cancer: from leukaemia to solid tumours. Nat Rev Cancer. 2013;13:559-571. [PMID: 23842646 DOI: 10.1038/nrc3563] [Cited by in Crossref: 249] [Cited by in F6Publishing: 217] [Article Influence: 27.7] [Reference Citation Analysis]
3 Wang N, Chen S, Zhang B, Li S, Jin F, Gao D, Liu H, Jiang Y. 8u, a pro-apoptosis/cell cycle arrest compound, suppresses invasion and metastasis through HSP90α downregulating and PI3K/Akt inactivation in hepatocellular carcinoma cells. Sci Rep 2018;8:309. [PMID: 29321577 DOI: 10.1038/s41598-017-18701-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Salvador E, Burek M, Förster CY. Tight Junctions and the Tumor Microenvironment. Curr Pathobiol Rep 2016;4:135-45. [PMID: 27547510 DOI: 10.1007/s40139-016-0106-6] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 6.3] [Reference Citation Analysis]
5 Babkair H, Yamazaki M, Uddin MS, Maruyama S, Abé T, Essa A, Sumita Y, Ahsan MS, Swelam W, Cheng J, Saku T. Aberrant expression of the tight junction molecules claudin-1 and zonula occludens-1 mediates cell growth and invasion in oral squamous cell carcinoma. Hum Pathol 2016;57:51-60. [PMID: 27436828 DOI: 10.1016/j.humpath.2016.07.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
6 Tong R, Yang B, Xiao H, Peng C, Hu W, Weng X, Cheng S, Du C, Lv Z, Ding C, Zhou L, Xie H, Wu J, Zheng S. KCTD11 inhibits growth and metastasis of hepatocellular carcinoma through activating Hippo signaling. Oncotarget 2017;8:37717-29. [PMID: 28465479 DOI: 10.18632/oncotarget.17145] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
7 Huang A, Zhou H, Zhao H, Quan Y, Feng B, Zheng M. TMPRSS4 correlates with colorectal cancer pathological stage and regulates cell proliferation and self-renewal ability. Cancer Biol Ther 2014;15:297-304. [PMID: 24335200 DOI: 10.4161/cbt.27308] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
8 Fields MA, Del Priore LV, Adelman RA, Rizzolo LJ. Interactions of the choroid, Bruch's membrane, retinal pigment epithelium, and neurosensory retina collaborate to form the outer blood-retinal-barrier. Prog Retin Eye Res 2020;76:100803. [PMID: 31704339 DOI: 10.1016/j.preteyeres.2019.100803] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
9 Tripathi R, Liu Z, Plattner R. EnABLing Tumor Growth and Progression: Recent progress in unraveling the functions of ABL kinases in solid tumor cells. Curr Pharmacol Rep 2018;4:367-79. [PMID: 30746323 DOI: 10.1007/s40495-018-0149-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
10 Achari C, Winslow S, Larsson C. Down Regulation of CLDND1 Induces Apoptosis in Breast Cancer Cells. PLoS One 2015;10:e0130300. [PMID: 26083392 DOI: 10.1371/journal.pone.0130300] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
11 Aoyama T, Takasawa A, Murata M, Osanai M, Takano K, Hasagawa T, Sawada N. Immunoreactivity patterns of tight junction proteins are useful for differential diagnosis of human salivary gland tumors. Med Mol Morphol 2019;52:23-35. [PMID: 29955965 DOI: 10.1007/s00795-018-0199-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
12 Roehlen N, Roca Suarez AA, El Saghire H, Saviano A, Schuster C, Lupberger J, Baumert TF. Tight Junction Proteins and the Biology of Hepatobiliary Disease. Int J Mol Sci 2020;21:E825. [PMID: 32012812 DOI: 10.3390/ijms21030825] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
13 Pyo JS, Kim NY, Cho WJ. Prognostic Role of Claudin-1 Immunohistochemistry in Malignant Solid Tumors: A Meta-Analysis. J Pathol Transl Med 2019;53:173-9. [PMID: 30832458 DOI: 10.4132/jptm.2019.02.03] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
14 Visco ZR, Sfakianos G, Grenier C, Boudreau MH, Simpson S, Rodriguez I, Whitaker R, Yao DY, Berchuck A, Murphy SK, Huang Z. Epigenetic Regulation of Claudin-1 in the Development of Ovarian Cancer Recurrence and Drug Resistance. Front Oncol 2021;11:620873. [PMID: 33828978 DOI: 10.3389/fonc.2021.620873] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Fouani L, Kovacevic Z, Richardson DR. Targeting Oncogenic Nuclear Factor Kappa B Signaling with Redox-Active Agents for Cancer Treatment. Antioxidants & Redox Signaling 2019;30:1096-123. [DOI: 10.1089/ars.2017.7387] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
16 English DP, Santin AD. Claudins overexpression in ovarian cancer: potential targets for Clostridium Perfringens Enterotoxin (CPE) based diagnosis and therapy. Int J Mol Sci 2013;14:10412-37. [PMID: 23685873 DOI: 10.3390/ijms140510412] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 3.7] [Reference Citation Analysis]
17 Liu J, Chanumolu SK, White KM, Albahrani M, Otu HH, Nawshad A. Transcriptional analysis of cleft palate in TGFβ3 mutant mice. Sci Rep 2020;10:14940. [PMID: 32913205 DOI: 10.1038/s41598-020-71636-0] [Reference Citation Analysis]
18 Ecoy GAU, Chamni S, Suwanborirux K, Chanvorachote P, Chaotham C. Jorunnamycin A from Xestospongia sp. Suppresses Epithelial to Mesenchymal Transition and Sensitizes Anoikis in Human Lung Cancer Cells. J Nat Prod 2019;82:1861-73. [PMID: 31260310 DOI: 10.1021/acs.jnatprod.9b00102] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
19 Ding X, Bai Y, Zhu X, Li T, Jin E, Huang L, Yu W, Zhao M. The effects of pleiotrophin in proliferative vitreoretinopathy. Graefes Arch Clin Exp Ophthalmol 2017;255:873-84. [DOI: 10.1007/s00417-016-3582-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
20 Venugopal S, Anwer S, Szászi K. Claudin-2: Roles beyond Permeability Functions. Int J Mol Sci 2019;20:E5655. [PMID: 31726679 DOI: 10.3390/ijms20225655] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
21 Leech AO, Cruz RG, Hill AD, Hopkins AM. Paradigms lost-an emerging role for over-expression of tight junction adhesion proteins in cancer pathogenesis. Ann Transl Med 2015;3:184. [PMID: 26366401 DOI: 10.3978/j.issn.2305-5839.2015.08.01] [Cited by in F6Publishing: 35] [Reference Citation Analysis]
22 Yamamoto D, Kayamori K, Sakamoto K, Tsuchiya M, Ikeda T, Harada H, Yoda T, Watabe T, Hara-Yokoyama M. Intracellular claudin-1 at the invasive front of tongue squamous cell carcinoma is associated with lymph node metastasis. Cancer Sci 2020;111:700-12. [PMID: 31769164 DOI: 10.1111/cas.14249] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
23 Guo JY, Hsu HS, Tyan SW, Li FY, Shew JY, Lee WH, Chen JY. Serglycin in tumor microenvironment promotes non-small cell lung cancer aggressiveness in a CD44-dependent manner. Oncogene. 2017;36:2457-2471. [PMID: 27819672 DOI: 10.1038/onc.2016.404] [Cited by in Crossref: 51] [Cited by in F6Publishing: 57] [Article Influence: 8.5] [Reference Citation Analysis]
24 Lu Y, Wang L, Li H, Li Y, Ruan Y, Lin D, Yang M, Jin X, Guo Y, Zhang X, Quan C. SMAD2 Inactivation Inhibits CLDN6 Methylation to Suppress Migration and Invasion of Breast Cancer Cells. Int J Mol Sci 2017;18:E1863. [PMID: 28867761 DOI: 10.3390/ijms18091863] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
25 Bhat AA, Syed N, Therachiyil L, Nisar S, Hashem S, Macha MA, Yadav SK, Krishnankutty R, Muralitharan S, Al-Naemi H, Bagga P, Reddy R, Dhawan P, Akobeng A, Uddin S, Frenneaux MP, El-Rifai W, Haris M. Claudin-1, A Double-Edged Sword in Cancer. Int J Mol Sci 2020;21:E569. [PMID: 31952355 DOI: 10.3390/ijms21020569] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
26 Boylan KL, Buchanan PC, Manion RD, Shukla DM, Braumberger K, Bruggemeyer C, Skubitz AP. The expression of Nectin-4 on the surface of ovarian cancer cells alters their ability to adhere, migrate, aggregate, and proliferate. Oncotarget 2017;8:9717-38. [PMID: 28038455 DOI: 10.18632/oncotarget.14206] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
27 Sun X, Wei B, Liu S, Guo C, Wu N, Liu Q, Sun MZ. Anxa5 mediates the in vitro malignant behaviours of murine hepatocarcinoma Hca-F cells with high lymph node metastasis potential preferentially via ERK2/p-ERK2/c-Jun/p-c-Jun(Ser73) and E-cadherin. Biomed Pharmacother 2016;84:645-54. [PMID: 27697636 DOI: 10.1016/j.biopha.2016.09.086] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
28 Singh AB, Dhawan P. Claudins and cancer: Fall of the soldiers entrusted to protect the gate and keep the barrier intact. Semin Cell Dev Biol. 2015;42:58-65. [PMID: 26025580 DOI: 10.1016/j.semcdb.2015.05.001] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 6.1] [Reference Citation Analysis]
29 Hou J, Ge C, Cui M, Liu T, Liu X, Tian H, Zhao F, Chen T, Cui Y, Yao M, Li J, Li H. Pigment epithelium-derived factor promotes tumor metastasis through an interaction with laminin receptor in hepatocellular carcinomas. Cell Death Dis 2017;8:e2969. [PMID: 28771223 DOI: 10.1038/cddis.2017.359] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
30 Liu M, Hu Q, Tu M, Wang X, Yang Z, Yang G, Luo R. MCM6 promotes metastasis of hepatocellular carcinoma via MEK/ERK pathway and serves as a novel serum biomarker for early recurrence. J Exp Clin Cancer Res 2018;37:10. [PMID: 29357919 DOI: 10.1186/s13046-017-0669-z] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 6.5] [Reference Citation Analysis]
31 Zhao N, Sun H, Sun B, Zhu D, Zhao X, Wang Y, Gu Q, Dong X, Liu F, Zhang Y, Li X. miR-27a-3p suppresses tumor metastasis and VM by down-regulating VE-cadherin expression and inhibiting EMT: an essential role for Twist-1 in HCC. Sci Rep 2016;6:23091. [PMID: 26980408 DOI: 10.1038/srep23091] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 8.5] [Reference Citation Analysis]
32 Li SL, Chen X, Wu T, Zhang XW, Li H, Zhang Y, Ji ZZ. Knockdown of TMPRSS3 inhibits gastric cancer cell proliferation, invasion and EMT via regulation of the ERK1/2 and PI3K/Akt pathways. Biomed Pharmacother 2018;107:841-8. [PMID: 30142546 DOI: 10.1016/j.biopha.2018.08.023] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
33 Alshbool FZ, Mohan S. Emerging multifunctional roles of Claudin tight junction proteins in bone. Endocrinology 2014;155:2363-76. [PMID: 24758302 DOI: 10.1210/en.2014-1173] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
34 Wong TS, Gao W, Chan JY. Transcription regulation of E-cadherin by zinc finger E-box binding homeobox proteins in solid tumors. Biomed Res Int 2014;2014:921564. [PMID: 25197668 DOI: 10.1155/2014/921564] [Cited by in Crossref: 29] [Cited by in F6Publishing: 47] [Article Influence: 3.6] [Reference Citation Analysis]
35 Zhang X, Wang H, Li Q, Liu Y, Zhao P, Li T. Differences in the expression profiles of claudin proteins in human nasopharyngeal carcinoma compared with non-neoplastic mucosa. Diagn Pathol 2018;13:11. [PMID: 29402318 DOI: 10.1186/s13000-018-0685-0] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
36 Remšík J, Binó L, Kahounová Z, Kharaishvili G, Šimecková Š, Fedr R, Kucírková T, Lenárt S, Muresan XM, Slabáková E, Knopfová L, Bouchal J, Král M, Beneš P, Soucek K. Trop-2 plasticity is controlled by epithelial-to-mesenchymal transition. Carcinogenesis 2018;39:1411-8. [PMID: 30010814 DOI: 10.1093/carcin/bgy095] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
37 Takasawa A, Murata M, Takasawa K, Ono Y, Osanai M, Tanaka S, Nojima M, Kono T, Hirata K, Kojima T, Sawada N. Nuclear localization of tricellulin promotes the oncogenic property of pancreatic cancer. Sci Rep 2016;6:33582. [PMID: 27641742 DOI: 10.1038/srep33582] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
38 Dunne LW, Huang Z, Meng W, Fan X, Zhang N, Zhang Q, An Z. Human decellularized adipose tissue scaffold as a model for breast cancer cell growth and drug treatments. Biomaterials. 2014;35:4940-4949. [PMID: 24661550 DOI: 10.1016/j.biomaterials.2014.03.003] [Cited by in Crossref: 82] [Cited by in F6Publishing: 77] [Article Influence: 10.3] [Reference Citation Analysis]
39 Lv J, Sun B, Mai Z, Jiang M, Du J. CLDN-1 promoted the epithelial to migration and mesenchymal transition (EMT) in human bronchial epithelial cells via Notch pathway. Mol Cell Biochem 2017;432:91-8. [PMID: 28316062 DOI: 10.1007/s11010-017-3000-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
40 Sharma RK, Chheda ZS, Das Purkayastha BP, Gomez-Gutierrez JG, Jala VR, Haribabu B. A spontaneous metastasis model reveals the significance of claudin-9 overexpression in lung cancer metastasis. Clin Exp Metastasis 2016;33:263-75. [PMID: 26669782 DOI: 10.1007/s10585-015-9776-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
41 Streubel G, Schrepfer S, Kallus H, Parnitzke U, Wulff T, Hermann F, Borgmann M, Hamm S. Histone deacetylase inhibitor resminostat in combination with sorafenib counteracts platelet-mediated pro-tumoral effects in hepatocellular carcinoma. Sci Rep 2021;11:9587. [PMID: 33953226 DOI: 10.1038/s41598-021-88983-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Dezső Z, Oestreicher J, Weaver A, Santiago S, Agoulnik S, Chow J, Oda Y, Funahashi Y. Gene expression profiling reveals epithelial mesenchymal transition (EMT) genes can selectively differentiate eribulin sensitive breast cancer cells. PLoS One 2014;9:e106131. [PMID: 25171249 DOI: 10.1371/journal.pone.0106131] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 4.6] [Reference Citation Analysis]
43 Li J. Context-Dependent Roles of Claudins in Tumorigenesis. Front Oncol 2021;11:676781. [PMID: 34354941 DOI: 10.3389/fonc.2021.676781] [Reference Citation Analysis]
44 Wang SB, Xu T, Peng S, Singh D, Ghiassi-Nejad M, Adelman RA, Rizzolo LJ. Disease-associated mutations of claudin-19 disrupt retinal neurogenesis and visual function. Commun Biol 2019;2:113. [PMID: 30937396 DOI: 10.1038/s42003-019-0355-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
45 Gao J, Zhu Y, Nilsson M, Sundfeldt K. TGF-β isoforms induce EMT independent migration of ovarian cancer cells. Cancer Cell Int 2014;14:72. [PMID: 25278811 DOI: 10.1186/s12935-014-0072-1] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 6.6] [Reference Citation Analysis]
46 Kyuno D, Takasawa A, Kikuchi S, Takemasa I, Osanai M, Kojima T. Role of tight junctions in the epithelial-to-mesenchymal transition of cancer cells. Biochim Biophys Acta Biomembr 2021;1863:183503. [PMID: 33189716 DOI: 10.1016/j.bbamem.2020.183503] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
47 Sun BS, Yao YQ, Pei BX, Zhang ZF, Wang CL. Claudin-1 correlates with poor prognosis in lung adenocarcinoma. Thorac Cancer 2016;7:556-63. [PMID: 27766775 DOI: 10.1111/1759-7714.12368] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
48 Kim JH, Shim JW, Eum DY, Kim SD, Choi SH, Yang K, Heo K, Park MT. Downregulation of UHRF1 increases tumor malignancy by activating the CXCR4/AKT-JNK/IL-6/Snail signaling axis in hepatocellular carcinoma cells. Sci Rep 2017;7:2798. [PMID: 28584306 DOI: 10.1038/s41598-017-02935-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
49 Hong J, Yuan YF, Wang JP, Liao Y, Zou RH, Zhu CL, Li BK, Liang Y, Huang PZ, Wang ZW, Lin WY, Zeng YX, Dai JL, Chung RT. Expression of variant isoforms of the tyrosine kinase SYK determines the prognosis of hepatocellular carcinoma. Cancer Res. 2014;74:1845-56. [PMID: 24477596 DOI: 10.1158/0008-5472.can-13-2104] [Cited by in Crossref: 27] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
50 Peng S, Wang S, Singh D, Zhao PY, Davis K, Chen B, Adelman RA, Rizzolo LJ. Claudin-3 and claudin-19 partially restore native phenotype to ARPE-19 cells via effects on tight junctions and gene expression. Experimental Eye Research 2016;151:179-89. [DOI: 10.1016/j.exer.2016.08.021] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
51 Chen Q, Yang D, Zong H, Zhu L, Wang L, Wang X, Zhu X, Song X, Wang J. Growth-induced stress enhances epithelial-mesenchymal transition induced by IL-6 in clear cell renal cell carcinoma via the Akt/GSK-3β/β-catenin signaling pathway. Oncogenesis 2017;6:e375. [PMID: 28846080 DOI: 10.1038/oncsis.2017.74] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]
52 Sun H, Cui C, Xiao F, Wang H, Xu J, Shi X, Yang Y, Zhang Q, Zheng X, Yang X, Wu C, Wang L. miR-486 regulates metastasis and chemosensitivity in hepatocellular carcinoma by targeting CLDN10 and CITRON. Hepatol Res 2015;45:1312-22. [PMID: 25655186 DOI: 10.1111/hepr.12500] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 4.6] [Reference Citation Analysis]
53 Bhat AA, Uppada S, Achkar IW, Hashem S, Yadav SK, Shanmugakonar M, Al-Naemi HA, Haris M, Uddin S. Tight Junction Proteins and Signaling Pathways in Cancer and Inflammation: A Functional Crosstalk. Front Physiol. 2019;9:1942. [PMID: 30728783 DOI: 10.3389/fphys.2018.01942] [Cited by in Crossref: 76] [Cited by in F6Publishing: 80] [Article Influence: 25.3] [Reference Citation Analysis]
54 Cheng X, Wang Y, Chen H, Xu Y, Xiong W, Wang T. Claudin-1 regulates pulmonary artery smooth muscle cell proliferation through the activation of ERK1/2. Biomed Pharmacother 2017;89:983-90. [PMID: 28292027 DOI: 10.1016/j.biopha.2017.02.063] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
55 Blanchard AA, Ma X, Wang N, Hombach-Klonisch S, Penner C, Ozturk A, Klonisch T, Pitz M, Murphy L, Leygue E, Myal Y. Claudin 1 Is Highly Upregulated by PKC in MCF7 Human Breast Cancer Cells and Correlates Positively with PKCε in Patient Biopsies. Transl Oncol 2019;12:561-75. [PMID: 30658316 DOI: 10.1016/j.tranon.2018.12.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
56 Gopal SK, Greening DW, Mathias RA, Ji H, Rai A, Chen M, Zhu HJ, Simpson RJ. YBX1/YB-1 induces partial EMT and tumourigenicity through secretion of angiogenic factors into the extracellular microenvironment. Oncotarget 2015;6:13718-30. [PMID: 25980435 DOI: 10.18632/oncotarget.3764] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 7.8] [Reference Citation Analysis]
57 Mahati S, Bolati D, Yang Y, Mao R, Zhang H, Bao Y. TMPRSS4 promotes cancer stem cell traits by regulating CLDN1 in hepatocellular carcinoma. Biochem Biophys Res Commun 2017;490:906-12. [PMID: 28651932 DOI: 10.1016/j.bbrc.2017.06.139] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
58 Mahati S, Xiao L, Yang Y, Mao R, Bao Y. miR-29a suppresses growth and migration of hepatocellular carcinoma by regulating CLDN1. Biochem Biophys Res Commun 2017;486:732-7. [PMID: 28342862 DOI: 10.1016/j.bbrc.2017.03.110] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 5.0] [Reference Citation Analysis]
59 Li DM, Zhang J, Li WM, Cui JT, Pan YM, Liu SQ, Xing R, Lu YY. MAWBP and MAWD inhibit proliferation and invasion in gastric cancer. World J Gastroenterol 2013; 19(18): 2781-2792 [PMID: 23687415 DOI: 10.3748/wjg.v19.i18.2781] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
60 Zhou Q, Wang X, Yu Z, Wu X, Chen X, Li J, Zhu Z, Liu B, Su L. Transducin (β)-like 1 X-linked receptor 1 promotes gastric cancer progression via the ERK1/2 pathway. Oncogene 2017;36:1873-86. [PMID: 27694893 DOI: 10.1038/onc.2016.352] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
61 Chei S, Oh HJ, Song JH, Seo YJ, Lee K, Lee BY. Magnolol Suppresses TGF-β-Induced Epithelial-to-Mesenchymal Transition in Human Colorectal Cancer Cells. Front Oncol 2019;9:752. [PMID: 31632899 DOI: 10.3389/fonc.2019.00752] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
62 Ouban A. Expression of Claudin-1 in laryngeal squamous cell carcinomas (LSCCs) and its significance. Histol Histopathol 2021;36:437-46. [PMID: 33629735 DOI: 10.14670/HH-18-320] [Reference Citation Analysis]
63 Hwang HS, Go H, Park JM, Yoon SY, Lee JL, Jeong SU, Cho YM. Epithelial-mesenchymal transition as a mechanism of resistance to tyrosine kinase inhibitors in clear cell renal cell carcinoma. Lab Invest 2019;99:659-70. [PMID: 30683903 DOI: 10.1038/s41374-019-0188-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
64 Sun L, Yao Y, Lu T, Shang Z, Zhan S, Shi W, Pan G, Zhu X, He S. DAB2IP Downregulation Enhances the Proliferation and Metastasis of Human Gastric Cancer Cells by Derepressing the ERK1/2 Pathway. Gastroenterol Res Pract 2018;2018:2968252. [PMID: 29743885 DOI: 10.1155/2018/2968252] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
65 Schwab RHM, Amin N, Flanagan DJ, Johanson TM, Phesse TJ, Vincan E. Wnt is necessary for mesenchymal to epithelial transition in colorectal cancer cells. Dev Dyn 2018;247:521-30. [PMID: 28560804 DOI: 10.1002/dvdy.24527] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
66 Deng M, Zhang Y, Liu B, Chen Y, Song H, Yu R, Che X, Qu X, Liu Y, Hu X, Xu X. β‐Elemene inhibits peritoneal metastasis of gastric cancer cells by modulating FAK/Claudin‐1 signaling. Phytotherapy Research 2019;33:2448-56. [DOI: 10.1002/ptr.6436] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
67 Mailly L, Xiao F, Lupberger J, Wilson GK, Aubert P, Duong FHT, Calabrese D, Leboeuf C, Fofana I, Thumann C, Bandiera S, Lütgehetmann M, Volz T, Davis C, Harris HJ, Mee CJ, Girardi E, Chane-Woon-Ming B, Ericsson M, Fletcher N, Bartenschlager R, Pessaux P, Vercauteren K, Meuleman P, Villa P, Kaderali L, Pfeffer S, Heim MH, Neunlist M, Zeisel MB, Dandri M, McKeating JA, Robinet E, Baumert TF. Clearance of persistent hepatitis C virus infection in humanized mice using a claudin-1-targeting monoclonal antibody. Nat Biotechnol 2015;33:549-54. [PMID: 25798937 DOI: 10.1038/nbt.3179] [Cited by in Crossref: 103] [Cited by in F6Publishing: 96] [Article Influence: 14.7] [Reference Citation Analysis]
68 Wang CC, Hsu YL, Chang CJ, Wang CJ, Hsiao TH, Pan SH. Inhibitor of DNA-Binding Protein 4 Suppresses Cancer Metastasis through the Regulation of Epithelial Mesenchymal Transition in Lung Adenocarcinoma. Cancers (Basel) 2019;11:E2021. [PMID: 31847356 DOI: 10.3390/cancers11122021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
69 Kuo KT, Chen CL, Chou TY, Yeh CT, Lee WH, Wang LS. Nm23H1 mediates tumor invasion in esophageal squamous cell carcinoma by regulation of CLDN1 through the AKT signaling. Oncogenesis 2016;5:e239. [PMID: 27376780 DOI: 10.1038/oncsis.2016.46] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
70 Kyuno D, Takasawa A, Takasawa K, Ono Y, Aoyama T, Magara K, Nakamori Y, Takemasa I, Osanai M. Claudin-18.2 as a therapeutic target in cancers: cumulative findings from basic research and clinical trials. Tissue Barriers 2021;:1967080. [PMID: 34486479 DOI: 10.1080/21688370.2021.1967080] [Reference Citation Analysis]
71 Stebbing J, Filipović A, Giamas G. Claudin-1 as a promoter of EMT in hepatocellular carcinoma. Oncogene 2013;32:4871-2. [PMID: 23318416 DOI: 10.1038/onc.2012.591] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 3.4] [Reference Citation Analysis]
72 Sheida F, Razi S, Keshavarz-Fathi M, Rezaei N. The role of myeloid-derived suppressor cells in lung cancer and targeted immunotherapies. Expert Rev Anticancer Ther 2021;:1-17. [PMID: 34821533 DOI: 10.1080/14737140.2022.2011224] [Reference Citation Analysis]
73 Clément CM, Deffieu MS, Dorobantu CM, Baumert TF, Ayala‐nunez NV, Mély Y, Ronde P, Gaudin R. Characterisation of endogenous Claudin‐1 expression, motility and susceptibility to hepatitis C virus in CRISPR knock‐in cells. Biol Cell 2020;112:140-51. [DOI: 10.1111/boc.201900085] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
74 Ogihara K, Ishihara A, Nagai M, Yamada K, Mizutani T, Harafuji M, Nishio H, Madarame H. Equine sarcoid of the glans penis with bovine papillomavirus type 1 in a miniature horse (Falabella). J Vet Med Sci 2021;83:1016-21. [PMID: 33907057 DOI: 10.1292/jvms.21-0170] [Reference Citation Analysis]
75 Endo A, Ly T, Pippa R, Bensaddek D, Nicolas A, Lamond AI. The Chromatin Assembly Factor Complex 1 (CAF1) and 5-Azacytidine (5-AzaC) Affect Cell Motility in Src-transformed Human Epithelial Cells. J Biol Chem 2017;292:172-84. [PMID: 27872192 DOI: 10.1074/jbc.M116.751024] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
76 Zhang Y, Li J, Jia S, Wang Y, Kang Y, Zhang W. Down-regulation of lncRNA-ATB inhibits epithelial-mesenchymal transition of breast cancer cells by increasing miR-141-3p expression. Biochem Cell Biol 2019;97:193-200. [PMID: 30352165 DOI: 10.1139/bcb-2018-0168] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 5.5] [Reference Citation Analysis]
77 Kwon MJ. Emerging roles of claudins in human cancer. Int J Mol Sci 2013;14:18148-80. [PMID: 24009024 DOI: 10.3390/ijms140918148] [Cited by in Crossref: 110] [Cited by in F6Publishing: 108] [Article Influence: 12.2] [Reference Citation Analysis]
78 Zeisel MB, Dhawan P, Baumert TF. Tight junction proteins in gastrointestinal and liver disease. Gut 2019;68:547-61. [PMID: 30297438 DOI: 10.1136/gutjnl-2018-316906] [Cited by in Crossref: 51] [Cited by in F6Publishing: 50] [Article Influence: 12.8] [Reference Citation Analysis]
79 Lu Y, Dang Q, Bo Y, Su X, Wang L, Sun J, Wei J, Quan C, Li Y. The Expression of CLDN6 in Hepatocellular Carcinoma Tissue and the Effects of CLDN6 on Biological Phenotypes of Hepatocellular Carcinoma Cells. J Cancer 2021;12:5454-63. [PMID: 34405008 DOI: 10.7150/jca.55727] [Reference Citation Analysis]
80 Bhat AA, Ahmad R, Uppada SB, Singh AB, Dhawan P. Claudin-1 promotes TNF-α-induced epithelial-mesenchymal transition and migration in colorectal adenocarcinoma cells. Exp Cell Res 2016;349:119-27. [PMID: 27742576 DOI: 10.1016/j.yexcr.2016.10.005] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 5.2] [Reference Citation Analysis]
81 Majer A, Blanchard AA, Medina S, Booth SA, Myal Y. Claudin 1 Expression Levels Affect miRNA Dynamics in Human Basal-Like Breast Cancer Cells. DNA Cell Biol 2016;35:328-39. [PMID: 26982264 DOI: 10.1089/dna.2015.3188] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
82 Yang L, Wang T, Zhang J, Liu Z, Wang X. Expression of BTBD7 in primary salivary adenoid cystic carcinoma and correlation with Slug and prognosis. Cancer Biomark 2016;17:179-85. [PMID: 27540976 DOI: 10.3233/CBM-160629] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
83 Li WH, Qiu Y, Zhang HQ, Liu Y, You JF, Tian XX, Fang WG. P2Y2 receptor promotes cell invasion and metastasis in prostate cancer cells. Br J Cancer 2013;109:1666-75. [PMID: 23969730 DOI: 10.1038/bjc.2013.484] [Cited by in Crossref: 64] [Cited by in F6Publishing: 63] [Article Influence: 7.1] [Reference Citation Analysis]
84 Amoozadeh Y, Anwer S, Dan Q, Venugopal S, Shi Y, Branchard E, Liedtke E, Ailenberg M, Rotstein OD, Kapus A, Szászi K. Cell confluence regulates claudin-2 expression: possible role for ZO-1 and Rac. American Journal of Physiology-Cell Physiology 2018;314:C366-78. [DOI: 10.1152/ajpcell.00234.2017] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
85 Cumin C, Huang YL, Everest-Dass A, Jacob F. Deciphering the Importance of Glycosphingolipids on Cellular and Molecular Mechanisms Associated with Epithelial-to-Mesenchymal Transition in Cancer. Biomolecules 2021;11:62. [PMID: 33418847 DOI: 10.3390/biom11010062] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
86 Huang J, Zhang L, He C, Qu Y, Li J, Zhang J, Du T, Chen X, Yu Y, Liu B, Zhu Z. Claudin-1 enhances tumor proliferation and metastasis by regulating cell anoikis in gastric cancer. Oncotarget 2015;6:1652-65. [PMID: 25544763 DOI: 10.18632/oncotarget.2936] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 4.6] [Reference Citation Analysis]
87 Huang C, Ho C, Tu S, Pan M, Chuang C, Chang H, Chang C, Wu C, Ho Y. Long-Term Ethanol Exposure-Induced Hepatocellular Carcinoma Cell Migration and Invasion through Lysyl Oxidase Activation Are Attenuated by Combined Treatment with Pterostilbene and Curcumin Analogues. J Agric Food Chem 2013;61:4326-35. [DOI: 10.1021/jf4004175] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
88 Szaszi K, Amoozadeh Y. New Insights into Functions, Regulation, and Pathological Roles of Tight Junctions in Kidney Tubular Epithelium. Elsevier; 2014. pp. 205-71. [DOI: 10.1016/b978-0-12-800097-7.00006-3] [Cited by in Crossref: 23] [Cited by in F6Publishing: 12] [Article Influence: 2.9] [Reference Citation Analysis]
89 Blanchard AA, Zelinski T, Xie J, Cooper S, Penner C, Leygue E, Myal Y. Identification of Claudin 1 Transcript Variants in Human Invasive Breast Cancer. PLoS One 2016;11:e0163387. [PMID: 27649506 DOI: 10.1371/journal.pone.0163387] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
90 Sun L, Feng L, Cui J. Increased expression of claudin-17 promotes a malignant phenotype in hepatocyte via Tyk2/Stat3 signaling and is associated with poor prognosis in patients with hepatocellular carcinoma. Diagn Pathol 2018;13:72. [PMID: 30219077 DOI: 10.1186/s13000-018-0749-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
91 Yang YL, Chang YH, Li CJ, Huang YH, Tsai MC, Chu PY, Lin HY. New Insights into the Role of miR-29a in Hepatocellular Carcinoma: Implications in Mechanisms and Theragnostics. J Pers Med 2021;11:219. [PMID: 33803804 DOI: 10.3390/jpm11030219] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
92 Kozieł MJ, Ziaja M, Piastowska-Ciesielska AW. Intestinal Barrier, Claudins and Mycotoxins. Toxins (Basel) 2021;13:758. [PMID: 34822542 DOI: 10.3390/toxins13110758] [Reference Citation Analysis]
93 Perkins TN, Peeters PM, Shukla A, Arijs I, Dragon J, Wouters EF, Reynaert NL, Mossman BT. Indications for distinct pathogenic mechanisms of asbestos and silica through gene expression profiling of the response of lung epithelial cells. Hum Mol Genet 2015;24:1374-89. [PMID: 25351596 DOI: 10.1093/hmg/ddu551] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
94 Zhou B, Moodie A, Blanchard AA, Leygue E, Myal Y. Claudin 1 in Breast Cancer: New Insights. J Clin Med 2015;4:1960-76. [PMID: 26633531 DOI: 10.3390/jcm4121952] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 4.7] [Reference Citation Analysis]
95 Sun Y, Chen C, Zhang P, Xie H, Hou L, Hui Z, Xu Y, Du Q, Zhou X, Su B, Gao W. Reduced miR-3127-5p expression promotes NSCLC proliferation/invasion and contributes to dasatinib sensitivity via the c-Abl/Ras/ERK pathway. Sci Rep 2014;4:6527. [PMID: 25284075 DOI: 10.1038/srep06527] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
96 Amoozadeh Y, Dan Q, Anwer S, Huang HH, Barbieri V, Waheed F, Maishan M, Szászi K. Tumor Necrosis Factor-α Increases Claudin-1, 4, and 7 Expression in Tubular Cells: Role in Permeability Changes: REGULATION OF CLAUDINS AND TER BY TNF. J Cell Physiol 2017;232:2210-20. [DOI: 10.1002/jcp.25736] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
97 Tang YL, Fan YL, Jiang J, Li KD, Zheng M, Chen W, Ma XR, Geng N, Chen QM, Chen Y, Liang XH. C-kit induces epithelial-mesenchymal transition and contributes to salivary adenoid cystic cancer progression. Oncotarget 2014;5:1491-501. [PMID: 24721839 DOI: 10.18632/oncotarget.1606] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
98 Luttman JH, Colemon A, Mayro B, Pendergast AM. Role of the ABL tyrosine kinases in the epithelial-mesenchymal transition and the metastatic cascade. Cell Commun Signal 2021;19:59. [PMID: 34022881 DOI: 10.1186/s12964-021-00739-6] [Reference Citation Analysis]
99 Cingir Koker S, Jahja E, Shehwana H, Keskus AG, Konu O. Cholinergic Receptor Nicotinic Alpha 5 (CHRNA5) RNAi is associated with cell cycle inhibition, apoptosis, DNA damage response and drug sensitivity in breast cancer. PLoS One 2018;13:e0208982. [PMID: 30543688 DOI: 10.1371/journal.pone.0208982] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
100 Liu K, Zhang X, Xu W, Chen J, Yu J, Gamble JR, McCaughan GW. Targeting the vasculature in hepatocellular carcinoma treatment: Starving vs normalizing blood supply.Clin Transl Gastroenterol. 2017;8:e98. [DOI: 10.1038/ctg.2017.28] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 8.4] [Reference Citation Analysis]
101 Wu X, Xiao J, Zhao C, Zhao C, Han Z, Wang F, Yang Y, Jiang Y, Fang F. Claudin1 promotes the proliferation, invasion and migration of nasopharyngeal carcinoma cells by upregulating the expression and nuclear entry of β-catenin. Exp Ther Med 2018;16:3445-51. [PMID: 30233694 DOI: 10.3892/etm.2018.6619] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
102 Feng S, Zhai J, Lu D, Lin J, Dong X, Liu X, Wu H, Roden AC, Brandi G, Tavolari S, Bille A, Cai K. TUSC3 accelerates cancer growth and induces epithelial-mesenchymal transition by upregulating claudin-1 in non-small-cell lung cancer cells. Exp Cell Res 2018;373:44-56. [PMID: 30098333 DOI: 10.1016/j.yexcr.2018.08.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
103 Alqahtani T, Alswied A, Sun D. Selective Antitumor Activity of Datelliptium toward Medullary Thyroid Carcinoma by Downregulating RET Transcriptional Activity. Cancers (Basel) 2021;13:3288. [PMID: 34209165 DOI: 10.3390/cancers13133288] [Reference Citation Analysis]
104 Chen YJ, You ML, Chong QY, Pandey V, Zhuang QS, Liu DX, Ma L, Zhu T, Lobie PE. Autocrine Human Growth Hormone Promotes Invasive and Cancer Stem Cell-Like Behavior of Hepatocellular Carcinoma Cells by STAT3 Dependent Inhibition of CLAUDIN-1 Expression. Int J Mol Sci 2017;18:E1274. [PMID: 28617312 DOI: 10.3390/ijms18061274] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
105 Vantangoli MM, Madnick SJ, Wilson S, Boekelheide K. Estradiol Exposure Differentially Alters Monolayer versus Microtissue MCF-7 Human Breast Carcinoma Cultures. PLoS One 2016;11:e0157997. [PMID: 27379522 DOI: 10.1371/journal.pone.0157997] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
106 Li Z, Xuan W, Huang L, Chen N, Hou Z, Lu B, Wen C, Huang S. Claudin 10 acts as a novel biomarker for the prognosis of patients with ovarian cancer. Oncol Lett 2020;20:373-81. [PMID: 32565963 DOI: 10.3892/ol.2020.11557] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
107 Basu M, Sengupta I, Khan MW, Srivastava DK, Chakrabarti P, Roy S, Das C. Dual histone reader ZMYND8 inhibits cancer cell invasion by positively regulating epithelial genes. Biochemical Journal 2017;474:1919-34. [DOI: 10.1042/bcj20170223] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
108 Holczbauer Á, Gyöngyösi B, Lotz G, Törzsök P, Kaposi-novák P, Szijártó A, Tátrai P, Kupcsulik P, Schaff Z, Kiss A. Increased Expression of Claudin-1 and Claudin-7 in Liver Cirrhosis and Hepatocellular Carcinoma. Pathol Oncol Res 2014;20:493-502. [DOI: 10.1007/s12253-013-9683-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
109 Baghbani E, Noorolyai S, Shanehbandi D, Mokhtarzadeh A, Aghebati-Maleki L, Shahgoli VK, Brunetti O, Rahmani S, Shadbad MA, Baghbanzadeh A, Silvestris N, Baradaran B. Regulation of immune responses through CD39 and CD73 in cancer: Novel checkpoints. Life Sci 2021;282:119826. [PMID: 34265363 DOI: 10.1016/j.lfs.2021.119826] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
110 Qin W, Ren Q, Liu T, Huang Y, Wang J. MicroRNA-155 is a novel suppressor of ovarian cancer-initiating cells that targets CLDN1. FEBS Lett. 2013;587:1434-1439. [PMID: 23523916 DOI: 10.1016/j.febslet.2013.03.023] [Cited by in Crossref: 85] [Cited by in F6Publishing: 85] [Article Influence: 9.4] [Reference Citation Analysis]
111 Panwar S, Sharma S, Tripathi P. Role of Barrier Integrity and Dysfunctions in Maintaining the Healthy Gut and Their Health Outcomes. Front Physiol 2021;12:715611. [PMID: 34630140 DOI: 10.3389/fphys.2021.715611] [Reference Citation Analysis]
112 Holczbauer Á, Gyöngyösi B, Lotz G, Szijártó A, Kupcsulik P, Schaff Z, Kiss A. Distinct claudin expression profiles of hepatocellular carcinoma and metastatic colorectal and pancreatic carcinomas. J Histochem Cytochem. 2013;61:294-305. [PMID: 23385421 DOI: 10.1369/0022155413479123] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
113 Zhang X, Jiang G, Sun M, Zhou H, Miao Y, Liang M, Wang E, Zhang Y. Cytosolic THUMPD1 promotes breast cancer cells invasion and metastasis via the AKT-GSK3-Snail pathway. Oncotarget 2017;8:13357-66. [PMID: 28076326 DOI: 10.18632/oncotarget.14528] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
114 Kletukhina S, Neustroeva O, James V, Rizvanov A, Gomzikova M. Role of Mesenchymal Stem Cell-Derived Extracellular Vesicles in Epithelial-Mesenchymal Transition. Int J Mol Sci 2019;20:E4813. [PMID: 31569731 DOI: 10.3390/ijms20194813] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]